Frontlight ResearchEarly access
Trial site
Centro Especializado En Diabetes, Obesidad Y Prevencion De Enfermedades Cardiovasculares
- 7running trials
- 8closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Obesity9 trials
- Type 2 diabetes9 trials
- Obstructive sleep apnoea3 trials
- Chronic kidney disease2 trials
- Stroke2 trials
- Coronary artery disease1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Heart failure1 trial
- Peripheral artery disease1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 313 trials
- Phase 21 trial
- Phase 41 trial
- Status
- Completed8 trials
- Active, not recruiting4 trials
- Recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Eli Lilly and Company15 trials
Running trials
Not yet recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic kidney disease1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Obesity1 recruiting
- Stroke1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
Completed
Completed
Completed
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
Completed
Completed
Completed
Completed
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight
Site data: ClinicalTrials.govUpdated 18 Nov 2026